“`html
{
"@context": "https://schema.org",
"@type": "FAQPage",
"mainEntity":[
{
"@type": "Question",
"name": "How is the role of pharmacists evolving in oncology?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Pharmacists are increasingly moving into outpatient settings, becoming embedded in clinics to improve efficiency and patient care. They are taking on medication management roles, helping clinics see more patients by freeing up physicians and advanced practice providers."
}
},
{
"@type": "Question",
"name": "What are the key areas where pharmacists are leading change in cancer care delivery?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Pharmacists are leading change by optimizing medication reconciliation, managing drug shortages, and reducing emergency visits through remote pharmacist interventions. They also play a crucial role in ensuring the right patients are treated in the appropriate setting, whether inpatient or outpatient."
}
},
{
"@type": "Question",
"name": "What are the barriers to integrating pharmacists into multidisciplinary cancer care teams?",
"acceptedAnswer": {
"@type": "Answer",
"text": "Common barriers include a lack of understanding among providers about the pharmacist's role, the time it takes for integration into the team (typically 3-6 months), and pharmacists needing to embrace expanded responsibilities beyond dispensing medications."
}
},
{
"@type": "Question",
"name": "What gaps exist in training for oncology pharmacists?",
"acceptedAnswer": {
"@type": "Answer",
"text": "There is insufficient oncology teaching at the student level in pharmacy schools. Additionally,the rapid pace of new drug approvals and the
